From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's diseaseTalita P.C. Chierrito, Ivone Carvalho, F. Javier Cañada et al.|European Journal of Medicinal Chemistry|2017Cited by 54
Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's diseasePeterson de Andrade, Ivone Carvalho, Nuria E. Campillo et al.|Bioorganic & Medicinal Chemistry|2018Cited by 42